Concentrica LLC

Stoke Therapeutics, Inc., based in Bedford, MA, is pioneering RNA medicine with its proprietary platform, Targeted Augmentation of Nuclear Gene Output (TANGO), aimed at restoring protein expression in diseases caused by gene mutations. The company's focus is primarily on conditions characterized by haploinsufficiencies, including Dravet syndrome and autosomal dominant optic atrophy (ADOA). Stoke's mission is to develop innovative therapies that address the genetic underpinnings of severe diseases, exemplified by their ongoing clinical studies of zorevunersen (STK-001) for Dravet syndrome. Through their commitment to scientific advancement, they aim to improve the lives of patients living with challenges associated with genetic disorders. Generated from the website

Physicians Ancillary Services, now a part of CortiCare since its acquisition in 2019, specializes in exceptional out-patient EEG services. Their offerings include remote EEG monitoring, in-home ambulatory EEG, reading and consulting services, and involvement in clinical trials. CortiCare continues to expand its services through innovative resources such as the CortiCare Podcast, quality assurance initiatives, and scientific webinars. Their commitment to quality and safety ensures that patients receive reliable and advanced EEG monitoring and analysis. Generated from the website